https://www.selleckchem.com/pr....oducts/Idarubicin.ht
1%). Overall, 36.0% of patients were overweight/obese (body mass index ≥25 kg/m ) and 18.6% had a history of neoplasms. The prevalence of comorbid conditions/complications tended to increase with advancing age and duration of T2DM. We revealed a high prevalence of comorbid conditions/complications, including chronic kidney and cardiovascular diseases, in Japanese patients with T2DM. We revealed a high prevalence of comorbid conditions/complications, including chronic kidney and cardiovascular diseases, in Japanese patients with T2DM.